Trial Profile
A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf(Tacrolimus)/ Myfortic and Advagraf (Extended Release Tacrolimus) / Myfortic in de Novo Liver Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2011
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolic acid
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 05 Oct 2011 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2010 Preliminary results in 20 patients presented at the 23rd International Congress of the Transplantation Society.